REPORTUM
LIVE

Serial Number

79141292

Owner

MyMedsandMe Limited

Attorney

Alexis P. Grilli

Filing Date

Jul 25, 2013

Add to watchlist:

No watchlists yet
View on USPTO

REPORTUM Trademark

Serial Number: 79141292 • Registration: 4562037

REPORTUM is a trademark filed by MyMedsandMe Limited on July 25, 2013. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MyMedsandMe Limited (4 trademarks)

2 Crossways Business Centre
Aylesbury, HP18 0RA , GB

Entity Type: 99

Trademark Details

Filing Date

July 25, 2013

Registration Date

July 8, 2014

Published for Opposition

April 22, 2014

Goods & Services

Computer software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said reactions and events and producing reports regarding such reactions and events; computer programs for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; computer software applications for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events

Telecommunications services, namely, transmission by means of telecommunications networks, wireless communication networks and the Internet of information, data and reports concerning reactions and events arising from the use of medication and pharmaceuticals; providing access to online databases which capture data relating to reactions and events arising from the use of medication and pharmaceuticals, enable follow up questions regarding such reactions and events and contain reports regarding said reactions and events; data transmission and reception services via telecommunication means, namely, data transmission and reception services relating to reactions and events arising from the use of medication and pharmaceuticals; telecommunication services, namely, providing access between patients or health care professionals and pharmaceutical companies to an electronic exchange of medical records concerning reactions and events arising from the use of medication and pharmaceuticals via a global computer network

Software as a service (SAAS) services featuring software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; providing temporary use of on-line non-downloadable software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, as well as enabling follow-up questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; maintenance of computer software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals and enables follow-up questions and answers regarding said reactions and events

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 18, 2025 NA71
REGISTERED-SEC.71 ACCEPTED
May 18, 2025 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 6, 2025 APRE
TEAS SECTION 71 RECEIVED
Jan 8, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jul 8, 2023 REM4
INTERNATIONAL REGISTRATION RENEWED
Feb 24, 2023 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jan 5, 2021 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Jan 5, 2021 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 7, 2020 APRE
TEAS SECTION 71 & 15 RECEIVED
Aug 20, 2020 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 8, 2019 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 19, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 4, 2014 FICS
FINAL DISPOSITION PROCESSED
Dec 4, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 8, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 8, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 22, 2014 NPUB
PUBLISHED FOR OPPOSITION
Apr 22, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Apr 18, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 2, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 2, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 2, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 15, 2014 PREV
ASSIGNED TO LIE
Mar 15, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 28, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2014 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 28, 2014 TCCA
REFUSAL PROCESSED BY IB
Feb 12, 2014 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 21, 2014 RFCS
REFUSAL PROCESSED BY MPU
Jan 21, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 19, 2014 RFCR
NON-FINAL ACTION WRITTEN
Jan 18, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 17, 2014 MAFR
ASSIGNED TO EXAMINER
Jan 13, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2014 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 10, 2014 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 10, 2014 REPR